NEUPOGEN
NEUPOGEN
Approved
DIN Number
02420112
Drug Class
Human
Market Date
Feb 2, 2016
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02420112
AIG Number0123525003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L03AA02 FILGRASTIM
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intravenous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FILGRASTIMActive
Strength: 600 MCG / ML
Monograph: FILGRASTIM